Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting-Reference-Cited by-同舟云学术

Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting

Published:2018-02 Issue:1 Volume:16 Page:50-57
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Oh William K.,Miao Raymond,Vekeman Francis,Sung Jennifer,Cheng Wendy Y.,Gauthier-Loiselle Marjolaine,Dhawan Ravinder,Duh Mei Sheng

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference23 articles.

1. Cancer Facts & Figures 2015,2015

2. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

3. Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapies;Mukherji;Cancer Metastasis Rev,2014

4. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion;Harris;Nat Clin Pract Urol,2009

5. Chemotherapy in prostate cancer;Hurwitz;Curr Oncol Rep,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer;Cells;2024-04-12

2. Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer;JAMA Oncology;2023-12-01

3. Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial;European Journal of Cancer;2022-09

4. Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management;Diagnostics;2022-02-24

5. Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospective analysis;International Journal of Clinical Oncology;2021-11-15